European Journal of Gynaecological Oncology. 2026; 47(3): 153-153. doi: 10.22514/ejgo.2026.050
Correction

Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2

Chunhui Wang1,*,, Suwei Lan1, Bing Han1, Xingcha Wang1

1Department of Gynecology, Affiliated Hospital of Chengde Medical University, 067000 Chengde, Hebei, China

*Corresponding Author(s):chunhui1233@163.com (Chunhui Wang)

History Published: 15 October 2026
Copyright:  ©2026 The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

No abstract available.

Keywords:None.
PDF(231.66 kB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Chunhui Wang, Suwei Lan, Bing Han, Xingcha Wang. Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2. European Journal of Gynaecological Oncology. 2026; 47(3): 153-153. doi: 10.22514/ejgo.2026.050

The authors wish to issue the following correction to the published article [1]:

Three citations in the Introduction and Discussion sections were not optimally matched to the supported statements. These have been replaced with more appropriate and directly relevant references. These changes do not affect the results, their interpretation, or the overall conclusions of the study.

Revised References:

The corrected references are as follows:

[6] Kim JH, Kim SI, Park EY, Ha HI, Kim JW, Coleman RL, et al. Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: a systematic review and meta-analysis. Gynecologic Oncology. 2023; 179: 24–32.

[7] Kongkamsuan W, Boonyapipat S. Epithelial ovarian cancer in younger age versus older age groups: survival and clinicopathological features. Journal of Cancer Research and Therapeutics. 2024; 20: 363–368.

[22] Li S, Yang M, Zhao R, Peng L, Liu W, Jiang X, et al. Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy. Genes & Diseases. 2023; 10: 2572–2585.

The authors sincerely apologize for any inconvenience or confusion caused by the previous citations and confirm that this correction does not affect the scientific conclusions or overall findings of the study.

References

Wang CH, Lan SW, Han B, Wang XC. Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2. European Journal of Gynaecological Oncology. 2024; 45: 62–67.

[Google Scholar]